
Kilitch Drugs Upgraded to Hold as Technicals Improve Despite Valuation Concerns
2026-11-16 08:01:57Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a nuanced shift in its technical outlook amid an expensive valuation and mixed financial trends. The upgrade, effective from 13 Nov 2026, is driven primarily by improved technical indicators, while valuation and financial performance present a more complex picture for investors.
Read More
Kilitch Drugs (India) Ltd Sees Bullish Momentum Shift Amid Technical Upgrades
2026-11-16 08:00:25Kilitch Drugs (India) Ltd has demonstrated a notable shift in technical momentum, with key indicators signalling a transition from a mildly bullish to a bullish trend. The stock’s recent price action, combined with positive signals from MACD, Bollinger Bands, and moving averages, suggests growing investor confidence amid a volatile pharmaceutical sector backdrop.
Read More
Kilitch Drugs Valuation Shifts to Expensive Amid Strong Market Returns
2026-11-16 08:00:14Kilitch Drugs (India) Ltd has witnessed a notable change in its valuation parameters, shifting from a fair to an expensive rating. This development, coupled with its recent price movements and peer comparisons, invites a closer examination of its price attractiveness and investment potential within the Pharmaceuticals & Biotechnology sector.
Read More
Kilitch Drugs (India) Ltd is Rated Hold by MarketsMOJO
2026-11-15 10:10:41Kilitch Drugs (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 November 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 November 2026, providing investors with an up-to-date perspective on the company’s standing.
Read MoreKilitch Drugs Falls 3.23%: 5 Key Factors Shaping This Week’s Volatility
2026-11-08 14:00:39Key Events This Week 2 Nov: Technical momentum shifts to mildly bullish; valuation moves to fair 3 Nov: Mojo Grade upgraded to Hold; bullish technical momentum 4 Nov: Downgrade to Sell amid valuation and technical concerns 5 Nov: Technical momentum rebounds to bullish stance 6 Nov: Sharp 6.08% drop on heavy volume closes the week Week OpenRs.201.00</di...
Read More
Kilitch Drugs (India) Ltd Technical Momentum Shifts Amid Mixed Market Returns
2026-11-05 08:00:49Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a micro-cap classification and a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators reveal a complex picture of strength and caution, with key metrics such as MACD and moving averages signalling upward momentum while others like KST and Dow Theory remain inconclusive.
Read More
Kilitch Drugs Downgraded to Sell Amid Valuation and Technical Concerns
2026-11-04 08:02:15Kilitch Drugs (India) Ltd has seen its investment rating downgraded from Hold to Sell following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. Despite some long-term growth achievements, recent quarterly results and shifting market dynamics have prompted a more cautious stance from analysts.
Read More
Kilitch Drugs (India) Ltd: Technical Momentum Shifts Amid Mixed Market Signals
2026-11-04 08:00:51Kilitch Drugs (India) Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish trend as of early November 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with some signals pointing to sustained strength while others suggest caution for investors navigating the Pharmaceuticals & Biotechnology sector.
Read MoreKilitch Drugs Declines 1.23% Despite Mixed Technical Momentum and Downgrade
2026-11-01 14:00:34Key Events This Week 26 Oct: Stock opens at ₹203.50, declines 2.11% amid cautious sentiment 27 Oct: Downgrade to Sell by MarketsMOJO announced; stock rebounds 4.52% to ₹208.20 28 Oct: Technical momentum upgrades to bullish; stock gains 3.05% to ₹214.55 29 Oct: Profit-taking leads to 2.73% decline to ₹208.70 30 Oct: Week closes with 3.69% drop to ₹201.00, underperforming Sensex Week Open<...
Read MoreShareholder Meeting / Postal Ballot-Scrutinizer"s Report
16-Nov-2026 | Source : BSEWe are submitting Scrutinizers Report for evoting of EGM
Shareholder Meeting / Postal Ballot-Outcome of EGM
16-Nov-2026 | Source : BSEProceeding of EGM held today i.e. 16th November 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2026 | Source : BSENewspaper Publication of Corrigendum to EGM Notice
Corporate Actions
No Upcoming Board Meetings
Kilitch Drugs (India) Ltd has declared 5% dividend, ex-date: 20 Sep 19
No Splits history available
Kilitch Drugs (India) Ltd has announced 1:1 bonus issue, ex-date: 24 Mar 26
Kilitch Drugs (India) Ltd has announced 2:23 rights issue, ex-date: 15 Jul 25